from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2841c/nusA

LFCtreatmentdescriptionclass of inhibitor

0.196

Amikacinug/mL Amikacintranslation

0.456

Cap5-10ug/mL Capreomycintranslation

1.736

Rox10-50 ug/mL Roxithromycintranslation

-0.320

SM2-5 ug/mL Streptomycintranslation

1.320

Tet5-10 ug/mL Tetracyclinetranslation

0.780

Rif0.2-5ug/mL Rifampicintranscription

0.590

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.107

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.709

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.615

CPZ10-50 ug/mL Chlorpromazinerespiration

1.441

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.229

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.939

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.032

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.016

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.419

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.043

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.827

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.137

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.459

KCN5-20 ug/mL Potassium cyaniderespiration

-0.509

NaN30.2-2 mM Sodium aziderespiration

0.662

Nigericin50 uM Nigericinrespiration

0.694

TRC10-150 ug/mL Triclosanrespiration

0.961

TRZ10-25 ug/mL Thioridazinerespiration

0.712

Valinomycin0.5-10 uM Valinomycinrespiration

-1.136

ZnSO42 mM ZnSO4respiration

0.940

menadione6-10 ug/mL Menadionerespiration

0.053

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.769

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.094

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.014

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.758

NRP_1Non-replicating persistence stage 1dosRassociated

-0.405

Amp0.2mg/mL AmpicillincellWall

-0.741

Cephalexin20-100 ug/mL CephalexincellWall

-0.632

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.308

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.433

EMB10-20 ug/mL EthambutolcellWall

-0.494

Eta12-40 ug/mL EthionamidecellWall

-0.693

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.245

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.254

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.783

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.130

BZA0.12 mg/mL BenzamidearomaticAmides

-0.289

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.600

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.811

H2O24 mM hydrogen peroxideDNAdamaging

-0.826

Levo10 ug/mL LevofloxacinDNAdamaging

-0.617

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.006

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.063

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.828

UVUV-irradiationDNAdamaging

2.081

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.722

Antimycin12.5-50 ug/mL Antimycin A?

-0.152

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.561

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.153

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.407

PA8240.2-2 ug/mL PA-824?

0.862

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.372

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.351

Verapamil50 uM Verapamil?

-0.356

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.536

methoxatin10-20 ug/mL Methoxatin?